Shell Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Shell Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,687	Closed	-$256K	–	1437
2020 Q2	$256K	Sell	7,687 -66	-0.9%	-$2.1K	0.01%	951
2020 Q1	$211K	Sell	7,753 -117	-1%	-$3.26K	0.01%	994
2019 Q4	$155K	Sell	7,870 -155	-2%	-$2.48K	﹤0.01%	1158
2019 Q3	$104K	Sell	8,025 -69	-0.9%	-$833	﹤0.01%	1191
2019 Q2	$101K	Buy	+8,094	New	+$107K	﹤0.01%	1171

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Shell Asset Management's MNTA Position: Q3 2020 in Review

Shell Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 7,687 shares — an estimated $256K sold.

Shell Asset Management first reported a position in MNTA in Q2 2019 and held it in 5 quarters. The position peaked at $256K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Shell Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Shell Asset Management sold 7,687 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $256K.
Shell Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2019 and held it in 5 quarters.
Shell Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $256K in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Shell Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.